Göksu, A. Y. Et Al. 2024. Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.. Pharmacology research & perspectives , vol.12, no.5 .

Göksu, A. Y., DİROL, H., & Kocanci, F. G., (2024). Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.. Pharmacology research & perspectives , vol.12, no.5.

Göksu, AZİZE, HÜLYA DİROL, And Fatma Gonca Kocanci. "Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.," Pharmacology research & perspectives , vol.12, no.5, 2024

Göksu, AZİZE Y. Et Al. "Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.." Pharmacology research & perspectives , vol.12, no.5, 2024

Göksu, A. Y. DİROL, H. And Kocanci, F. G. (2024) . "Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.." Pharmacology research & perspectives , vol.12, no.5.

@article{article, author={AZİZE YASEMİN GÖKSU EROL Et Al. }, title={Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.}, journal={Pharmacology research & perspectives}, year=2024}